Helicobacter Pylori Diagnostics Market to witness outstanding growth of USD 926.8 million by 2032 | Avanos Medical, Gulf Coast Scientific, Quidel Corporation, Biohit Oyj

According to the report, the global Helicobacter pylori diagnostics industry generated $552.7 million in 2022, and is anticipated to generate $926.8 million by 2032, witnessing a CAGR of 5.3% from 2023 to 2032. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

✅ The non-invasive test segment to maintain its leadership status throughout the forecast period
✅ The laboratory based test segment to dominate in terms of revenue during the forecast period
✅ The diagnostic laboratories segment to maintain its lead position during the forecast period
✅ North America to maintain its dominance by 2032.

Request Sample Copy of Report: www.alliedmarketresearch.com/request-sample/3543

The global Helicobacter pylori diagnostics market is majorly driven by an increase in prevalence of infectious diseases such as gastric cancer, rise in advancements in technology to diagnose H. pylori infection, and surge in awareness about H.

pylori testing. Rise in advances in diagnostic technology have made it easier and more efficient to detect H. pylori infection, which drives the demand for diagnostic tests and supports the market growth.

Market Segmentation:

By Type of Test:

✅ Invasive Tests: These tests require endoscopy and involve direct visualization of the stomach lining for H. pylori presence. Examples include:
✅ Rapid urease test (RUT): Detects urease enzyme produced by H. pylori.
✅ Biopsy: Tissue sample is taken and tested for H. pylori infection.
✅ Non-invasive Tests: These tests are non-invasive and avoid the need for endoscopy. Examples include:
✅ Stool antigen test (SAT): Detects H. pylori antigens in stool.
✅ Urea breath test (UBT): Measures the presence of H. pylori by analyzing breath after ingesting a urea-based solution.
Serological tests: Detect H. pylori antibodies in blood.

By Application:

✅ Hospitals and Clinics: These are the primary settings where H. pylori diagnostics are performed.
✅ Diagnostic Laboratories: Specialized labs offer H. pylori testing services to healthcare providers and patients.
✅ Home Testing Kits: Over-the-counter kits are available for home use, but accuracy and interpretation of results can be challenging.

By Geography:

✅ North America: Has the largest market share due to high awareness and advanced healthcare infrastructure.
✅ Europe: A mature market with strong adoption of H. pylori testing.
✅ Asia Pacific: This region is experiencing rapid growth due to rising disposable income and increasing awareness.
✅ Latin America: A growing market with potential for significant expansion.

By Technology:

✅ Traditional methods: Standard RUT, UBT, and serological tests.
✅ Advanced technologies: Next-generation sequencing, molecular assays, and rapid point-of-care tests.

Request for Customization: www.alliedmarketresearch.com/request…ation/3543

Regional Growth Dynamics:

North America held the largest market share in terms of revenue in 2022, accounting for around two-fifths of the global Helicobacter pylori diagnostics market revenue, and is likely to dominate the market during the forecast period. Easy availability of products for the diagnosis of H.

pylori bacteria, advanced healthcare infrastructure, and a rise in the adoption of non-invasive methods promoted the growth of the Helicobacter pylori diagnostics market in North America. However, the Asia-Pacific region is expected to exhibit the fastest CAGR of 6.3% from 2023 to 2032.

An increase in the prevalence of infectious diseases such as gastric cancer along with growing awareness about early diagnosis is expected to drive the growth of the Helicobacter pylori diagnostics market.

For Purchase Inquiry- www.alliedmarketresearch.com/purchas…quiry/3543

Leading Market Players:

✅ Thermo Fisher Scientific Inc.
✅ Meridian Bioscience, Inc.
✅ Bio-Rad Laboratories, Inc.
✅ Abbott Laboratories
✅ F. Hoffmann-La Roche Ltd.
✅ Cardinal Health Inc.
✅ Avanos Medical, Inc.
✅ Gulf Coast Scientific
✅ Quidel Corporation
✅ Biohit Oyj

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.